Stay updated on SGN-PDL1V in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated to v3.5.4, replacing v3.5.3. This indicates a new version of the page with minor edits rather than changes to the study data.
    Difference
    0.0%
    Check dated 2026-05-15T15:11:19.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The page’s metadata reflects a newer update and the site’s revision version has changed (from `v3.5.2` to `v3.5.3`), with related update dates adjusted accordingly. No changes to the core study details (e.g., eligibility criteria, interventions, outcomes, or recruiting locations) are indicated.
    Difference
    0.2%
    Check dated 2026-04-24T05:54:08.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a backend/maintenance version bump with no visible changes to the study details.
    Difference
    0.0%
    Check dated 2026-04-17T02:29:23.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Hepatocellular carcinoma was added to the list of conditions, and the page revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T06:11:17.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T23:46:55.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Added hepatocellular carcinoma, endometrial cancer, and pancreatic adenocarcinoma as study indications; updated the study locations to 61 sites.
    Difference
    2%
    Check dated 2026-02-25T18:36:26.000Z thumbnail image

Stay in the know with updates to SGN-PDL1V in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page.